Cepheid, Sunnyvale, California, has been awarded a maximum $565,781,250 fixed-price, indefinite-delivery/indefinite-quantity contract for multiplex point-of-care nucleic acid amplification tests, confirmatory tests and analyzers for influenza A, influenza B, Respiratory Syncytial Virus and COVID-19. This was a competitive acquisition with two responses received. This is an 18-month contract with no option periods. Location of performance is California, with a Sept. 3, 2023, ordering period end date. Using customer is the Department of Health and Human Services. Type of appropriation is fiscal 2022 through 2023 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DE-22-D-0017).